16 May 2022 - Durvalumab recommended as an option for treating non-small-cell lung cancer. ...
13 May 2022 - Hundreds of people with a form of the most common form of lung cancer could survive ...
11 May 2022 - NICE has published evidence based recommendations on the use of avelumab for adults with locally advanced ...
27 April 2022 - NICE has published evidence-based recommendations on the use of tucatinib for the treatment of adults with ...
27 April 2022 - NICE has published evidence-based recommendations on the use of venetoclax in combination with low dose cytosine ...
20 April 2022 - This is the first appraisal of nivolumab to be terminated by NICE. ...
14 April 2022 - An innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced ...
7 April 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
13 April 2022 - NICE has published evidence based recommendations on the use of daratumumab (Darzalex) for the treatment of ...
7 April 2022 - NICE has today issued draft guidance which does not recommend sacituzumab govitecan for treating locally advanced or ...
7 April 2022 - Over 800 people with locally advanced or metastatic urothelial cancer are set to benefit from a new ...
30 March 2022 - Tagraxofusp is human interleukin-3 genetically conjugated to diphtheria toxin protein. ...
24 March 2022 - NICE has published evidence-based recommendations on nivolumab (Opdivo) with ipilimumab (Yervoy) for untreated advanced renal cell ...
21 March 2022 - The NICE method guide for technology appraisals encourages medicine manufacturers to use the EuroQol 5 Dimension in ...
18 March 2022 - A targeted new drug for a rare and aggressive form of lung cancer will be fast-tracked ...